Home > Portfolio > Yugo Development, LLC.
Portfolio Companies

Yugo Development, LLC.

Domain: Healthcare
Area: Japan

Yugo Development, LLC. is developing the next generation of antiviral drugs for the treatment of Human Immunodeficiency Virus (HIV) infection. The discovery research is focused on small molecule HIV fusion inhibitors that block HIV fusion events.

Company Yugo Development, LLC.
Portfolio Companies
  • United States
  • Japan
  • China
  • Other
  • United States
  • Japan
  • China
  • United States
  • Japan
  • United States
  • China

News Release

09/27/2010 11/01/2010
MVC Corporation Changes Name to Mitsui & Co. Global Investment, Ltd. 09/27/2010 11/01/2010
MCVP Changes Name and Relocates Office 09/27/2010 09/27/2010
Notice on Relocation of MVC Head Office 09/24/2010 09/24/2010
Mitsui Ventures invested USD 5 M in S*BIO Taro Inaba 06/17/2008 | Taro Inaba
Boehringer Ingelheim announced an agreement to acquire Actimis Pharmaceuticals, Inc. one of our portfolio firms.